Market Overview:
The global gastroesophageal reflux disease (GERD) treatment device market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of GERD, technological advancements in GERD treatment devices, and rising demand for minimally invasive surgery. The global gastroesophageal reflux disease (GERD) treatment device market is segmented by type into invasive surgery and non-invasive surgery. The invasive surgery segment is further sub-segmented into open surgical procedures and laparoscopic surgical procedures. The non-invasive surgery segment is further sub-segmented into endoscopic procedures and radiologic procedures. The endoscopic procedure segment accounted for the largest share of the global gastroesophageal reflux disease (GERD) treatment device market in 2017 owing to its high adoption rate across regions. However, the radiologic procedure segment is expected to grow at a higher CAGR during the forecast period due to its growing popularity among patients owing to its less intrusive nature as compared with other types of treatments available in the market.
Product Definition:
Gastroesophageal reflux disease is a condition that can cause significant discomfort and health problems. The gastroesophageal reflux disease treatment device helps to prevent these problems by keeping the esophagus open and preventing stomach acid from flowing back up into the esophagus.
Invasive Surgery:
Invasive surgery is a term used to define surgical procedures that are performed in a patient's own home or hospital with the goal of eliminating or reducing the severity of a medical condition. These surgeries are generally more effective, less traumatic and have fewer side effects compared to traditional open surgeries. The most common type of invasive procedure performed today is gastroesophageal reflux disease (GERD) treatment using devices such as rigid endoscopes, video cameras and pill mills.
Non Invasive Surgery:
Non-invasive surgery (NIS) is a type of treatment that involves the surgical procedures without making incisions. These surgeries are performed to treat conditions like heart diseases, cancer, and gastroesophageal reflux disease (GERD). The major advantage of these surgeries is that there are no open wounds after the completion of the procedure.
Application Insights:
Based on application, the global gastroesophageal reflux disease treatment device market is segmented into government, hospitals and medical practitioners, others. The hospital and medical practitioner application segments dominated the overall market in terms of revenue share in 2017. This can be attributed to a high prevalence of gastroesophageal reflux disease (GERD) coupled with an increasing number of hospital admissions for this condition. In addition, factors such as rising awareness about available treatment options among general physicians along with a growing preference for invasive procedures are also contributing towards higher market penetration by this segment.
The other segment includes commercial organizations as well as non-profit organizations that provide support services to patients suffering from GERD or other associated conditions such as esophagitis and Barrett¢â‚¬â„¢s Esophagus which often goes hand-in-hand with GERD.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing awareness about GERD, growing geriatric population, and availability of advanced treatments. Moreover, high adoption of technologically advanced medical devices is also contributing towards regional growth.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising healthcare expenditure by governments and private sectors in order to improve patient care facilities across various countries including China, India Japan & South Korea among others are some of the emerging markets for GERD treatment devices in Asia Pacific region that have witnessed significant economic development over past few years which has led towards an increase in demand for such products as well as services associated with it’s treatment & diagnosis.
Growth Factors:
- Increasing incidence of Gastroesophageal Reflux Disease (GERD)
- Growing demand for minimally invasive procedures
- Technological advancements in GERD treatment devices
- Rising awareness about GERD and its treatment options
- increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Gastroesophageal Reflux Disease Treatment Device Market Research Report
By Type
Invasive Surgery, Non Invasive Surgery
By Application
Government, Hospitals, Medical Practitioners, Others
By Companies
BD, MEDERI THERAPEUTICS, Medigus Ltd, Torax Medical, EndoGastric Solutions, BD
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
150
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Gastroesophageal Reflux Disease Treatment Device Market Report Segments:
The global Gastroesophageal Reflux Disease Treatment Device market is segmented on the basis of:
Types
Invasive Surgery, Non Invasive Surgery
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Government, Hospitals, Medical Practitioners, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD
- MEDERI THERAPEUTICS
- Medigus Ltd
- Torax Medical
- EndoGastric Solutions
- BD
Highlights of The Gastroesophageal Reflux Disease Treatment Device Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Invasive Surgery
- Non Invasive Surgery
- By Application:
- Government
- Hospitals
- Medical Practitioners
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gastroesophageal Reflux Disease Treatment Device Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A gastroesophageal reflux disease treatment device is a medical device that helps to reduce or prevent the occurrence of gastroesophageal reflux disease (GERD). Devices may help to improve symptoms, such as heartburn, by reducing the amount of stomach acid that flows back up into the esophagus.
Some of the key players operating in the gastroesophageal reflux disease treatment device market are BD, MEDERI THERAPEUTICS, Medigus Ltd, Torax Medical, EndoGastric Solutions, BD.
The gastroesophageal reflux disease treatment device market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Gastroesophageal Reflux Disease Treatment Device Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Gastroesophageal Reflux Disease Treatment Device Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Gastroesophageal Reflux Disease Treatment Device Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Gastroesophageal Reflux Disease Treatment Device Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Gastroesophageal Reflux Disease Treatment Device Market Size & Forecast, 2018-2028
4.5.1 Gastroesophageal Reflux Disease Treatment Device Market Size and Y-o-Y Growth
4.5.2 Gastroesophageal Reflux Disease Treatment Device Market Absolute $ Opportunity
Chapter 5 Global Gastroesophageal Reflux Disease Treatment Device Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Gastroesophageal Reflux Disease Treatment Device Market Size Forecast by Type
5.2.1 Invasive Surgery
5.2.2 Non Invasive Surgery
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Gastroesophageal Reflux Disease Treatment Device Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Gastroesophageal Reflux Disease Treatment Device Market Size Forecast by Applications
6.2.1 Government
6.2.2 Hospitals
6.2.3 Medical Practitioners
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Gastroesophageal Reflux Disease Treatment Device Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Gastroesophageal Reflux Disease Treatment Device Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Gastroesophageal Reflux Disease Treatment Device Analysis and Forecast
9.1 Introduction
9.2 North America Gastroesophageal Reflux Disease Treatment Device Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Gastroesophageal Reflux Disease Treatment Device Market Size Forecast by Type
9.6.1 Invasive Surgery
9.6.2 Non Invasive Surgery
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Gastroesophageal Reflux Disease Treatment Device Market Size Forecast by Applications
9.10.1 Government
9.10.2 Hospitals
9.10.3 Medical Practitioners
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Gastroesophageal Reflux Disease Treatment Device Analysis and Forecast
10.1 Introduction
10.2 Europe Gastroesophageal Reflux Disease Treatment Device Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Gastroesophageal Reflux Disease Treatment Device Market Size Forecast by Type
10.6.1 Invasive Surgery
10.6.2 Non Invasive Surgery
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Gastroesophageal Reflux Disease Treatment Device Market Size Forecast by Applications
10.10.1 Government
10.10.2 Hospitals
10.10.3 Medical Practitioners
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Gastroesophageal Reflux Disease Treatment Device Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Gastroesophageal Reflux Disease Treatment Device Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Gastroesophageal Reflux Disease Treatment Device Market Size Forecast by Type
11.6.1 Invasive Surgery
11.6.2 Non Invasive Surgery
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Gastroesophageal Reflux Disease Treatment Device Market Size Forecast by Applications
11.10.1 Government
11.10.2 Hospitals
11.10.3 Medical Practitioners
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Gastroesophageal Reflux Disease Treatment Device Analysis and Forecast
12.1 Introduction
12.2 Latin America Gastroesophageal Reflux Disease Treatment Device Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Gastroesophageal Reflux Disease Treatment Device Market Size Forecast by Type
12.6.1 Invasive Surgery
12.6.2 Non Invasive Surgery
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Gastroesophageal Reflux Disease Treatment Device Market Size Forecast by Applications
12.10.1 Government
12.10.2 Hospitals
12.10.3 Medical Practitioners
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Gastroesophageal Reflux Disease Treatment Device Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Gastroesophageal Reflux Disease Treatment Device Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Gastroesophageal Reflux Disease Treatment Device Market Size Forecast by Type
13.6.1 Invasive Surgery
13.6.2 Non Invasive Surgery
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Gastroesophageal Reflux Disease Treatment Device Market Size Forecast by Applications
13.10.1 Government
13.10.2 Hospitals
13.10.3 Medical Practitioners
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Gastroesophageal Reflux Disease Treatment Device Market: Competitive Dashboard
14.2 Global Gastroesophageal Reflux Disease Treatment Device Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BD
14.3.2 MEDERI THERAPEUTICS
14.3.3 Medigus Ltd
14.3.4 Torax Medical
14.3.5 EndoGastric Solutions
14.3.6 BD
